Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 100
Summary
- Conditions
- Lupus Erythematosus, Systemic
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: open labelMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03427151
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon